Survey on myeloma patient information needs in 12 countries
Myeloma Patients Europe (MPE) has launched a survey for European myeloma patients to understand their information needs. If you are a myeloma patient who has received at least one prior treatment or is currently on their first treatment, MPE would be very grateful if you would take the time to complete the survey. The survey has been developed in collaboration with the pharmaceutical company Amgen and it is currently open in the UK, Germany, Austria, Finland, Poland, Romania, Sweden, The Netherlands, Switzerland and France and it will be open soon in Israel and Hungary. You can find the country-specific survey links and translations in all relevant languages in the link below.